Use of psychostimulants in the management of treatment-resistant major depressive disorder

Use of psychostimulants in the management of treatment-resistant major depressive disorder

Saved in:

Bibliographic Details
Main Author:	Sara L. Pucci, PharmD, BCPP
Format:	Article
Language:	English
Published:	American Association of Psychiatric Pharmacists 2025-08-01
Series:	Mental Health Clinician
Subjects:	depression treatment resistant psychostimulant
Online Access:	https://theijpt.org/doi/pdf/10.9740/mhc.2025.08.197
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Esketamine use in real-world clinical practice in patients with treatment-resistant depression
by: Ismael Conejero, et al.

Treatment-Resistant Depression: The Role of Electroconvulsive Therapy
by: Magdalena Kupis, et al.
Published: (2025-05-01)

Case Report: Intranasal esketamine combined with a form of generative artificial intelligence in the management of treatment-resistant depression
by: Alexandre Fraichot, et al.
Published: (2025-08-01)

New insights into the mechanisms of electroconvulsive therapy in treatment-resistant depression
by: Ana C. Ruiz, et al.
Published: (2025-08-01)

Changes in indicators of the prooxidant-antioxidant system in patients with drug addiction during the rehabilitation
by: I. M. Bykov, et al.
Published: (2022-06-01)

Amygdala subregional functional connectivity in treatment-resistant depression
by: Sheryl L. Foster, et al.
Published: (2025-07-01)

Esketamine nasal spray compassionate use program in the Netherlands: An open label, multi-center cohort study in severe treatment-resistant depression
by: Abel (K.A.J.) Busz, et al.
Published: (2025-04-01)

The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?
by: Trevor R. Norman
Published: (2025-08-01)

Comorbid medical illness as a predisposing factor for the treatment-resistant depression. Part 1: Mechanisms of treatment resistance
by: M. Yu. Popov
Published: (2018-07-01)

Treatment-resistant or difficult-to-treat depression: a consensus on the pharmacotherapy challenges and considerations for the health care system in Greece
by: Kyriakos Souliotis, et al.
Published: (2025-04-01)

Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trial
by: A. John Rush, et al.
Published: (2025-05-01)

Anxious Depression in Major Depressive Disorder: Key Influences and Prevalence in Chinese Hospitalized Patients
by: Zhu Y, et al.
Published: (2024-11-01)

Development of Yoga Intervention Module for Children and Adolescents with Major Depressive Disorder
by: Bichitra Nanda Patra, et al.
Published: (2025-01-01)

Clinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked database
by: Hrishikesh Kale, et al.
Published: (2025-07-01)

Re: Hernandez Bustamante et al. “Pharmacist administration of long-acting injectable medications for substance use disorders”
by: Jerry McKee, PharmD, MS, BCPP, et al.
Published: (2025-08-01)

Pathological changes in the heart under the use of psychostimulants
by: S. V. Kozlov, et al.
Published: (2019-01-01)

The Relationship Between Binge Eating Behavior and Psychological Pain in Patients with Major Depressive Disorder
by: Aynur Özbay, et al.
Published: (2025-06-01)

Altered brain regional homogeneity, depressive symptoms, and cognitive impairments in medication-free female patients with current depressive episodes in bipolar disorder and major depressive disorder
by: Sulin Ni, et al.
Published: (2024-12-01)

Longitudinal association between somatic symptoms and suicidal ideation in adults with major depressive disorder
by: Subinuer Yiming, et al.
Published: (2025-08-01)

Mechanistic intersections between migraine and major depressive disorder
by: Micah Johnson, et al.
Published: (2025-07-01)

Correlations between major depressive disorder, splenic morphology, and immune function
by: Zouqing Lin, et al.
Published: (2025-05-01)

Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution
by: Sakiko Tsugawa, et al.
Published: (2025-08-01)

The role and therapeutic potential of mitophagy in major depressive disorder
by: Xin-Nuan Shi, et al.
Published: (2025-03-01)

Facilitators and barriers to participation of patients with treatment resistant depression in a randomised controlled trial of two forms of personalised magnetic resonance imaging targeted transcranial magnetic stimulation (the BRIGhTMIND trial)
by: Clement Boutry, et al.
Published: (2025-07-01)

Vortioxetine for depression treatment in hospital setting: experience from a single psychiatric hospital
by: O. V. Limankin, et al.
Published: (2020-10-01)

Nutraceutical eicosapentaenoic acid in treatment-resistant depression: The psychoneuroimmunity and clinical implications
by: Jane Pei-Chen Chang, et al.
Published: (2025-08-01)

Serum L-selectin levels as predictive markers for chronic major depressive disorder progression
by: Yeeun Yun, et al.
Published: (2024-10-01)

Dealing with major depression in general practice
by: C.P. Freeman, et al.
Published: (2013-08-01)

Dealing with major depression in general practice
by: C.P. Freeman, et al.
Published: (2012-06-01)

APHOBAZOLUM AND PYRAZIDOL IN A COMPLEX TREATMENT OF THE PATIENTS WITH CORONARY HEART DISEASE AND ANXIETY AND DEPRESSIVE DISORDERS
by: E. V. Minakov, et al.
Published: (2009-12-01)

SEMIOTICS, DIAGNOSTICS AND THERAPY TACTICS OF DEPRESSIVE DISORDERS IN CLINICAL MEDICINE
by: N. A. Kornetov
Published: (2014-06-01)

Implementation of mMINDS monitoring for alcohol withdrawal at an inpatient academic psychiatric facility
by: Leah A. Surbaugh, PharmD, BCPP, et al.
Published: (2025-08-01)

The relationship between the changes in inflammatory parameters and response to treatment in major depression patients starting antidepressant treatment
by: Abdullah Burak Uygur, et al.
Published: (2021-08-01)

EFFECTIVE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE AND DEPRESSIVE DISORDERS WITH NOOTROPICS DRUG PANTOGAM ACTIV
by: A. P. Baranov, et al.
Published: (2016-03-01)

The Hidden Struggle: Depression Among Seniors
by: Magdalena Jabłonowska, et al.
Published: (2025-08-01)

THE CHOICE OF ANTIDEPRESSANTS FOR THE TREATMENT OF DEPRESSIVE DISORDERS ASSOCIATED WITH EPILEPSY
by: L. V. Lipatova, et al.
Published: (2016-12-01)

Suicide attempts in elderly Han Chinese patients with major depressive disorder: prevalence and associated factors
by: Xiaofan Zhou, et al.
Published: (2025-09-01)

Melatonin rhythm disorder is more pronounced in major depressive disorder with non-suicidal self-injury
by: Xiaojuan Hu, et al.
Published: (2025-05-01)

Accelerated repetitive transcranial magnetic stimulation in the treatment of depressive disorder resistant to a course of antidepressant medication
by: Mahtab Motamed, et al.
Published: (2025-05-01)

The central role of microglia in major depressive disorder and its potential as a therapeutic target
by: Xue Xia, et al.
Published: (2025-08-01)